2018-003701-26
A study to see the effect of Trivalent and Quadrivalent formulations of FluMist on the immune response of children 24 to < 48 months of age
MedImmune LLC·EU Clinical Trials Register
Study focus
- Disease/Condition
- Influenza
Sponsor & location
- Primary sponsor
- MedImmune LLC
- Funder
- MedImmune, LLC
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
History of allergic disease or reactions likely to be exacerbated by any component of the investigational product;
ICD-10 classifications
Need for immunization against influenzaInfluenza and pneumoniaInfluenza due to identified seasonal influenza virusNeed for immunization against plagueInfluenza, virus not identified
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2018-003701-26
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2018-003701-26 through Pure Global AI's free database. This phase not specified trial is sponsored by MedImmune LLC and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.